Breathing easier.

PositionNO COMMENT - Mylan Inc. chief Heather Bresch - Brief article

Heather Bresch, the CEO of the pharmaceutical company Mylan, told CNBC, "No ones more frustrated than me" that the price of her company's potentially life-saving EpiPen injectors rose by about 400 percent between 2007 and 2015. Bresch's hurt maybe somewhat assuaged by the fact that...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT